| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein serine kinase activity | SMG1 MAP2K4 MARK3 STK17A SPEG TSSK2 HUNK SIK3 MAPK1 MAPK3 TP53RK MAPK4 | 1.25e-06 | 363 | 115 | 12 | GO:0106310 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | SMG1 MAP2K4 MARK3 STK17A SPEG TSSK2 HUNK SIK3 MAPK1 MAPK3 TP53RK MAPK4 | 1.03e-05 | 446 | 115 | 12 | GO:0004674 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | SMG1 MAP2K4 MARK3 STK17A SPEG NT5C3A TSSK2 HUNK SIK3 PIP4K2A MAPK1 MAPK3 TP53RK MAPK4 FYN | 1.38e-05 | 709 | 115 | 15 | GO:0016773 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | SMG1 MAP2K4 MARK3 STK17A SPEG NT5C3A TSSK2 FPGT HUNK SIK3 PIP4K2A POLI MAPK1 MAPK3 TP53RK MAPK4 FYN | 2.61e-05 | 938 | 115 | 17 | GO:0016772 |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR2A14 OR2J2 OR2F1 OR10Z1 OR2K2 OR10AG1 OR4C15 OR2AT4 OR2Z1 OR4C5 OR2W6P | 3.96e-05 | 431 | 115 | 11 | GO:0004984 |
| GeneOntologyMolecularFunction | protein kinase activity | SMG1 MAP2K4 MARK3 STK17A SPEG TSSK2 HUNK SIK3 MAPK1 MAPK3 TP53RK MAPK4 FYN | 4.23e-05 | 600 | 115 | 13 | GO:0004672 |
| GeneOntologyMolecularFunction | hydroxyacylglutathione hydrolase activity | 9.83e-05 | 3 | 115 | 2 | GO:0004416 | |
| GeneOntologyMolecularFunction | MAP kinase activity | 9.87e-05 | 16 | 115 | 3 | GO:0004707 | |
| GeneOntologyMolecularFunction | kinase activity | SMG1 MAP2K4 MARK3 STK17A SPEG TSSK2 HUNK SIK3 PIP4K2A MAPK1 MAPK3 TP53RK MAPK4 FYN | 1.27e-04 | 764 | 115 | 14 | GO:0016301 |
| GeneOntologyMolecularFunction | tau-protein kinase activity | 2.65e-04 | 22 | 115 | 3 | GO:0050321 | |
| GeneOntologyMolecularFunction | dolichyl-diphosphooligosaccharide-protein glycotransferase activity | 3.25e-04 | 5 | 115 | 2 | GO:0004579 | |
| GeneOntologyMolecularFunction | oligosaccharyl transferase activity | 3.25e-04 | 5 | 115 | 2 | GO:0004576 | |
| GeneOntologyMolecularFunction | volume-sensitive anion channel activity | 1.15e-03 | 9 | 115 | 2 | GO:0005225 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR2A14 OR2J2 OR2F1 OR10Z1 OR2K2 OR10AG1 OR4C15 OR2AT4 OR2Z1 OR4C5 OR2W6P | 3.02e-05 | 432 | 115 | 11 | GO:0050911 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR2A14 OR2J2 OR2F1 OR10Z1 OR2K2 OR10AG1 OR4C15 OR2AT4 OR2Z1 OR4C5 OR2W6P | 5.88e-05 | 465 | 115 | 11 | GO:0007608 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR2A14 OR2J2 OR2F1 OR10Z1 OR2K2 OR10AG1 OR4C15 OR2AT4 OR2Z1 OR4C5 OR2W6P | 8.56e-05 | 485 | 115 | 11 | GO:0050907 |
| GeneOntologyBiologicalProcess | sensory perception | OR2A14 MYO7A OR2J2 OR2F1 OR10Z1 OR2K2 OR10AG1 OR4C15 OR2AT4 MAPK1 OR2Z1 MAPK3 FYN CNGA1 NIPBL OR4C5 OR2W6P | 9.17e-05 | 1072 | 115 | 17 | GO:0007600 |
| GeneOntologyBiologicalProcess | co-translational protein modification | 9.21e-05 | 3 | 115 | 2 | GO:0043686 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR2A14 OR2J2 OR2F1 OR10Z1 OR2K2 OR10AG1 OR4C15 OR2AT4 OR2Z1 FYN OR4C5 OR2W6P | 9.98e-05 | 582 | 115 | 12 | GO:0050906 |
| GeneOntologyCellularComponent | lysosome | LRRC8E FUT10 MYO7A IST1 APOB BLOC1S1 SLC66A1 AP2A1 PIP4K2A LRRC8A ARRDC3 MAPK1 DNAJC3 HSP90AA1 | 1.48e-04 | 811 | 115 | 14 | GO:0005764 |
| GeneOntologyCellularComponent | lytic vacuole | LRRC8E FUT10 MYO7A IST1 APOB BLOC1S1 SLC66A1 AP2A1 PIP4K2A LRRC8A ARRDC3 MAPK1 DNAJC3 HSP90AA1 | 1.48e-04 | 811 | 115 | 14 | GO:0000323 |
| Domain | S_TKc | MAP2K4 MARK3 STK17A SPEG TSSK2 HUNK SIK3 MAPK1 MAPK3 TP53RK MAPK4 | 1.05e-05 | 359 | 112 | 11 | SM00220 |
| Domain | Protein_kinase_ATP_BS | MAP2K4 MARK3 STK17A SPEG TSSK2 HUNK SIK3 MAPK1 MAPK3 MAPK4 FYN | 1.75e-05 | 379 | 112 | 11 | IPR017441 |
| Domain | PROTEIN_KINASE_ATP | MAP2K4 MARK3 STK17A SPEG TSSK2 HUNK SIK3 MAPK1 MAPK3 TP53RK MAPK4 FYN | 2.01e-05 | 459 | 112 | 12 | PS00107 |
| Domain | Kinase-like_dom | SMG1 MAP2K4 MARK3 STK17A SPEG TSSK2 HUNK SIK3 MAPK1 MAPK3 TP53RK MAPK4 FYN | 2.21e-05 | 542 | 112 | 13 | IPR011009 |
| Domain | MAPK_ERK1/2 | 3.56e-05 | 2 | 112 | 2 | IPR008349 | |
| Domain | STT3 | 3.56e-05 | 2 | 112 | 2 | PF02516 | |
| Domain | Oligo_trans_STT3 | 3.56e-05 | 2 | 112 | 2 | IPR003674 | |
| Domain | Prot_kinase_dom | MAP2K4 MARK3 STK17A SPEG TSSK2 HUNK SIK3 MAPK1 MAPK3 TP53RK MAPK4 FYN | 3.74e-05 | 489 | 112 | 12 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | MAP2K4 MARK3 STK17A SPEG TSSK2 HUNK SIK3 MAPK1 MAPK3 TP53RK MAPK4 FYN | 4.04e-05 | 493 | 112 | 12 | PS50011 |
| Domain | Ser/Thr_kinase_AS | 5.77e-05 | 357 | 112 | 10 | IPR008271 | |
| Domain | PROTEIN_KINASE_ST | 6.48e-05 | 362 | 112 | 10 | PS00108 | |
| Domain | Pkinase | 9.90e-05 | 381 | 112 | 10 | PF00069 | |
| Domain | Olfact_rcpt | OR2A14 OR2J2 OR2F1 OR10Z1 OR2K2 OR10AG1 OR4C15 OR2AT4 OR2Z1 OR4C5 | 1.28e-04 | 393 | 112 | 10 | IPR000725 |
| Domain | LRRC8_Pannexin-like | 3.52e-04 | 5 | 112 | 2 | IPR021040 | |
| Domain | Pannexin_like | 3.52e-04 | 5 | 112 | 2 | PF12534 | |
| Domain | CRAL-TRIO_dom | 6.17e-04 | 28 | 112 | 3 | IPR001251 | |
| Domain | CUT | 7.34e-04 | 7 | 112 | 2 | PS51042 | |
| Domain | CUT | 7.34e-04 | 7 | 112 | 2 | PF02376 | |
| Domain | CUT_dom | 7.34e-04 | 7 | 112 | 2 | IPR003350 | |
| Domain | CUT | 7.34e-04 | 7 | 112 | 2 | SM01109 | |
| Domain | Ca/CaM-dep_Ca-dep_prot_Kinase | 7.85e-04 | 69 | 112 | 4 | IPR020636 | |
| Domain | MAP_kinase_CS | 2.26e-03 | 12 | 112 | 2 | IPR003527 | |
| Domain | CRAL_TRIO_2 | 2.26e-03 | 12 | 112 | 2 | PF13716 | |
| Domain | Cullin_repeat-like_dom | 2.26e-03 | 12 | 112 | 2 | IPR016159 | |
| Domain | MAPK | 2.26e-03 | 12 | 112 | 2 | PS01351 | |
| Domain | 7tm_1 | OR2A14 MCHR1 OR2J2 OR2F1 OR10Z1 OR2K2 OR10AG1 OR4C15 OR2AT4 OR2Z1 OR4C5 | 2.49e-03 | 677 | 112 | 11 | PF00001 |
| Domain | Lactamase_B | 2.66e-03 | 13 | 112 | 2 | PF00753 | |
| Domain | G_PROTEIN_RECEP_F1_1 | OR2A14 MCHR1 OR2J2 OR2F1 OR10Z1 OR2K2 OR10AG1 OR4C15 OR2AT4 OR2Z1 OR4C5 | 2.73e-03 | 685 | 112 | 11 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR2A14 MCHR1 OR2J2 OR2F1 OR10Z1 OR2K2 OR10AG1 OR4C15 OR2AT4 OR2Z1 OR4C5 | 2.91e-03 | 691 | 112 | 11 | PS50262 |
| Domain | GPCR_Rhodpsn | OR2A14 MCHR1 OR2J2 OR2F1 OR10Z1 OR2K2 OR10AG1 OR4C15 OR2AT4 OR2Z1 OR4C5 | 2.95e-03 | 692 | 112 | 11 | IPR000276 |
| Domain | Lactamase_B | 3.56e-03 | 15 | 112 | 2 | SM00849 | |
| Pathway | PID_TELOMERASE_PATHWAY | 8.25e-05 | 67 | 94 | 5 | M105 | |
| Pathway | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | 9.91e-05 | 14 | 94 | 3 | MM15029 | |
| Pathway | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | 1.51e-04 | 16 | 94 | 3 | M16498 | |
| Pathway | SA_PTEN_PATHWAY | 1.82e-04 | 17 | 94 | 3 | M12771 | |
| Pathway | BIOCARTA_MAPK_PATHWAY | 2.03e-04 | 81 | 94 | 5 | M13863 | |
| Pathway | WP_IL11_SIGNALING | 2.05e-04 | 44 | 94 | 4 | M39716 | |
| Pathway | PID_ANTHRAX_PATHWAY | 2.18e-04 | 18 | 94 | 3 | M267 | |
| Pathway | BIOCARTA_ECM_PATHWAY | 2.57e-04 | 19 | 94 | 3 | M6355 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR2A14 MYO7A APOB OR2J2 OR2F1 OR10Z1 OR2K2 OR10AG1 OR4C15 OR2AT4 OR2Z1 CNGA1 OR4C5 | 2.95e-04 | 636 | 94 | 13 | M41834 |
| Pathway | WP_IL3_SIGNALING | 3.12e-04 | 49 | 94 | 4 | M39722 | |
| Pathway | BIOCARTA_ECM_PATHWAY | 3.50e-04 | 21 | 94 | 3 | MM1390 | |
| Pathway | BIOCARTA_CERAMIDE_PATHWAY | 3.50e-04 | 21 | 94 | 3 | M19943 | |
| Pathway | WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN | 3.50e-04 | 21 | 94 | 3 | M48342 | |
| Pathway | REACTOME_NPAS4_REGULATES_EXPRESSION_OF_TARGET_GENES | 4.03e-04 | 22 | 94 | 3 | M46437 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_USP8_TO_EGFR_ERK_ACTH_SIGNALING_PATHWAY | 4.34e-04 | 5 | 94 | 2 | M49028 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_BRAF_TO_ERK_SIGNALING_PATHWAY | 4.34e-04 | 5 | 94 | 2 | M49016 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_ERK_SIGNALING_PATHWAY | 4.34e-04 | 5 | 94 | 2 | M49004 | |
| Pathway | WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER | 4.34e-04 | 5 | 94 | 2 | M39621 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 4.34e-04 | 5 | 94 | 2 | MM1575 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR2A14 OR2J2 OR2F1 OR10Z1 OR2K2 OR10AG1 OR4C15 OR2AT4 OR2Z1 OR4C5 | 4.54e-04 | 417 | 94 | 10 | M4072 |
| Pathway | BIOCARTA_CERAMIDE_PATHWAY | 4.62e-04 | 23 | 94 | 3 | MM1367 | |
| Pathway | WP_CARDIAC_HYPERTROPHIC_RESPONSE | 4.87e-04 | 55 | 94 | 4 | M39685 | |
| Pathway | WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY | 5.17e-04 | 99 | 94 | 5 | MM15905 | |
| Pathway | WP_IL6_SIGNALING_PATHWAY | 5.41e-04 | 100 | 94 | 5 | MM15826 | |
| Pathway | PID_LYMPH_ANGIOGENESIS_PATHWAY | 5.94e-04 | 25 | 94 | 3 | M274 | |
| Pathway | WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION | 5.94e-04 | 25 | 94 | 3 | M39384 | |
| Pathway | REACTOME_MISCELLANEOUS_TRANSPORT_AND_BINDING_EVENTS | 5.94e-04 | 25 | 94 | 3 | MM15172 | |
| Pathway | WP_IL7_SIGNALING | 5.94e-04 | 25 | 94 | 3 | M39499 | |
| Pathway | WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY | 6.47e-04 | 104 | 94 | 5 | M39625 | |
| Pathway | BIOCARTA_SAM68_PATHWAY | 6.48e-04 | 6 | 94 | 2 | M22052 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 6.48e-04 | 6 | 94 | 2 | M22062 | |
| Pathway | REACTOME_NEGATIVE_FEEDBACK_REGULATION_OF_MAPK_PATHWAY | 6.48e-04 | 6 | 94 | 2 | M27559 | |
| Pathway | REACTOME_NEGATIVE_FEEDBACK_REGULATION_OF_MAPK_PATHWAY | 6.48e-04 | 6 | 94 | 2 | MM15273 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_OSPF_TO_TLR2_4_MAPK_SIGNALING_PATHWAY | 6.48e-04 | 6 | 94 | 2 | M47766 | |
| Pathway | BIOCARTA_SAM68_PATHWAY | 6.48e-04 | 6 | 94 | 2 | MM1567 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_F_RECEPTORS | 6.48e-04 | 6 | 94 | 2 | M27222 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ERK_RSK_SIGNALING | 6.48e-04 | 6 | 94 | 2 | M47936 | |
| Pathway | REACTOME_SIGNALING_BY_NODAL | 6.48e-04 | 6 | 94 | 2 | MM14517 | |
| Pathway | BIOCARTA_AT1R_PATHWAY | 6.68e-04 | 26 | 94 | 3 | MM1346 | |
| Pathway | PID_VEGFR1_PATHWAY | 6.68e-04 | 26 | 94 | 3 | M226 | |
| Pathway | REACTOME_MISCELLANEOUS_TRANSPORT_AND_BINDING_EVENTS | 6.68e-04 | 26 | 94 | 3 | M27424 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR2_4_MAPK_SIGNALING_PATHWAY | 6.68e-04 | 26 | 94 | 3 | M47565 | |
| Pathway | BIOCARTA_PYK2_PATHWAY | 6.68e-04 | 26 | 94 | 3 | MM1431 | |
| Pathway | PID_ALK1_PATHWAY | 6.68e-04 | 26 | 94 | 3 | M185 | |
| Pathway | PID_FCER1_PATHWAY | 6.80e-04 | 60 | 94 | 4 | M7 | |
| Pathway | BIOCARTA_AT1R_PATHWAY | 7.48e-04 | 27 | 94 | 3 | M14899 | |
| Pathway | BIOCARTA_PYK2_PATHWAY | 7.48e-04 | 27 | 94 | 3 | M7739 | |
| Pathway | WP_MAPK_CASCADE | 8.34e-04 | 28 | 94 | 3 | MM15976 | |
| Pathway | WP_IL19_SIGNALING | 8.34e-04 | 28 | 94 | 3 | M48111 | |
| Pathway | PID_TRAIL_PATHWAY | 8.34e-04 | 28 | 94 | 3 | M79 | |
| Pathway | REACTOME_IFNG_SIGNALING_ACTIVATES_MAPKS | 9.04e-04 | 7 | 94 | 2 | MM17070 | |
| Pathway | REACTOME_SIGNALING_BY_LTK_IN_CANCER | 9.04e-04 | 7 | 94 | 2 | M48255 | |
| Pathway | REACTOME_RSK_ACTIVATION | 9.04e-04 | 7 | 94 | 2 | M27369 | |
| Pathway | REACTOME_SUPPRESSION_OF_APOPTOSIS | 9.04e-04 | 7 | 94 | 2 | M29815 | |
| Pathway | BIOCARTA_BIOPEPTIDES_PATHWAY | 9.25e-04 | 29 | 94 | 3 | MM1356 | |
| Pathway | REACTOME_METALLOPROTEASE_DUBS | 9.25e-04 | 29 | 94 | 3 | MM15291 | |
| Pathway | BIOCARTA_BIOPEPTIDES_PATHWAY | 9.25e-04 | 29 | 94 | 3 | M13494 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PRNP_PI3K_NOX2_SIGNALING_PATHWAY | 9.25e-04 | 29 | 94 | 3 | M47764 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 9.81e-04 | 114 | 94 | 5 | MM14814 | |
| Pathway | REACTOME_M_PHASE | 1.10e-03 | 387 | 94 | 9 | MM15364 | |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | 1.14e-03 | 389 | 94 | 9 | M14091 | |
| Pathway | PID_VEGFR1_2_PATHWAY | 1.15e-03 | 69 | 94 | 4 | M237 | |
| Pathway | REACTOME_CELLULAR_SENESCENCE | 1.19e-03 | 119 | 94 | 5 | MM14901 | |
| Pathway | BIOCARTA_STAT3_PATHWAY | 1.20e-03 | 8 | 94 | 2 | M22063 | |
| Pathway | REACTOME_IFNG_SIGNALING_ACTIVATES_MAPKS | 1.20e-03 | 8 | 94 | 2 | M48010 | |
| Pathway | BIOCARTA_STAT3_PATHWAY | 1.20e-03 | 8 | 94 | 2 | MM1576 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PROK2_TO_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY | 1.20e-03 | 8 | 94 | 2 | M47642 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PROKR2_TO_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY | 1.20e-03 | 8 | 94 | 2 | M47643 | |
| Pathway | KEGG_RENAL_CELL_CARCINOMA | 1.21e-03 | 70 | 94 | 4 | M13266 | |
| Pathway | PID_CDC42_PATHWAY | 1.21e-03 | 70 | 94 | 4 | M81 | |
| Pathway | PID_ALPHA_SYNUCLEIN_PATHWAY | 1.24e-03 | 32 | 94 | 3 | M275 | |
| Pathway | WP_PRION_DISEASE_PATHWAY | 1.24e-03 | 32 | 94 | 3 | M39636 | |
| Pathway | PID_NETRIN_PATHWAY | 1.24e-03 | 32 | 94 | 3 | M108 | |
| Pathway | REACTOME_CELL_CYCLE_MITOTIC | CENPE RBL2 IST1 PSME1 ORC5 H2AC18 H2AC20 MAPK1 MAPK3 NIPBL HSP90AA1 | 1.25e-03 | 561 | 94 | 11 | M5336 |
| Pathway | REACTOME_BACTERIAL_INFECTION_PATHWAYS | 1.28e-03 | 71 | 94 | 4 | M48033 | |
| Pathway | PID_SYNDECAN_2_PATHWAY | 1.36e-03 | 33 | 94 | 3 | M240 | |
| Pathway | WP_MAPK_CASCADE | 1.36e-03 | 33 | 94 | 3 | M39594 | |
| Pathway | BIOCARTA_INTEGRIN_PATHWAY | 1.36e-03 | 33 | 94 | 3 | MM1426 | |
| Pathway | BIOCARTA_INTEGRIN_PATHWAY | 1.48e-03 | 34 | 94 | 3 | M3342 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES | 1.48e-03 | 34 | 94 | 3 | MM15265 | |
| Pathway | SIG_CD40PATHWAYMAP | 1.48e-03 | 34 | 94 | 3 | M12705 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4 | 1.48e-03 | 34 | 94 | 3 | M46422 | |
| Pathway | REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE | 1.48e-03 | 125 | 94 | 5 | M27186 | |
| Pathway | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | 1.54e-03 | 9 | 94 | 2 | MM15030 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY | 1.54e-03 | 9 | 94 | 2 | M47641 | |
| Pathway | REACTOME_SIGNALING_BY_NTRKS | 1.57e-03 | 75 | 94 | 4 | MM14652 | |
| Pathway | WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME | 1.61e-03 | 35 | 94 | 3 | M45521 | |
| Pathway | KEGG_PRION_DISEASES | 1.61e-03 | 35 | 94 | 3 | M13036 | |
| Pathway | BIOCARTA_MAPK_PATHWAY | 1.65e-03 | 76 | 94 | 4 | MM1433 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 1.69e-03 | 190 | 94 | 6 | MM15687 | |
| Pathway | PID_PDGFRB_PATHWAY | 1.70e-03 | 129 | 94 | 5 | M186 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES | 1.75e-03 | 36 | 94 | 3 | M27549 | |
| Pathway | WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING | 1.75e-03 | 36 | 94 | 3 | M39908 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 1.79e-03 | 261 | 94 | 7 | MM15676 | |
| Pathway | REACTOME_M_PHASE | 1.84e-03 | 417 | 94 | 9 | M27662 | |
| Pathway | REACTOME_METALLOPROTEASE_DUBS | 1.89e-03 | 37 | 94 | 3 | M27580 | |
| Pathway | REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE | 1.89e-03 | 37 | 94 | 3 | MM14899 | |
| Pathway | WP_NEOVASCULARIZATION_PROCESSES | 1.89e-03 | 37 | 94 | 3 | M39506 | |
| Pathway | KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY | 1.90e-03 | 79 | 94 | 4 | M11816 | |
| Pathway | REACTOME_SIGNAL_ATTENUATION | 1.91e-03 | 10 | 94 | 2 | M14236 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR2A14 OR2J2 OR2F1 OR10Z1 OR2K2 OR10AG1 OR4C15 OR2AT4 OR2Z1 OR4C5 OR2W6P | 1.91e-08 | 340 | 115 | 11 | 11875048 |
| Pubmed | OR2A14 OR2J2 OR2F1 OR10Z1 OR2K2 OR10AG1 OR4C15 OR2AT4 OR2Z1 OR4C5 OR2W6P | 1.91e-08 | 340 | 115 | 11 | 11802173 | |
| Pubmed | OR2A14 OR2J2 OR2F1 OR10Z1 OR2K2 OR10AG1 OR4C15 OR2AT4 OR2Z1 OR4C5 OR2W6P | 2.09e-08 | 343 | 115 | 11 | 32295537 | |
| Pubmed | OR2A14 OR2J2 OR2F1 OR10Z1 OR2K2 OR10AG1 OR4C15 OR2AT4 OR2Z1 OR4C5 OR2W6P | 2.28e-08 | 346 | 115 | 11 | 14611657 | |
| Pubmed | ZMYND10 functions in a chaperone relay during axonemal dynein assembly. | 2.35e-08 | 10 | 115 | 4 | 29916806 | |
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 21731758 | ||
| Pubmed | Heterogeneous expression of four MAP kinase isoforms in human tissues. | 3.52e-08 | 3 | 115 | 3 | 1319925 | |
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 33607074 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 15068691 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 8290275 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 26096876 | ||
| Pubmed | SMG1 CUX2 PCDHGA5 APOB XRCC5 SLC4A3 STT3B ARPC2 H2AC18 H2AC20 C6orf118 AP2A1 PIP4K2A STRN4 PLXNA4 IFT122 DNAJC3 NIPBL CUX1 HSP90AA1 | 5.37e-08 | 1442 | 115 | 20 | 35575683 | |
| Pubmed | Non-redundant role of Shc in Erk activation by cytoskeletal reorganization. | 1.41e-07 | 4 | 115 | 3 | 14576154 | |
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 22158075 | ||
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 16434965 | ||
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 12441075 | ||
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 18426913 | ||
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 19751964 | ||
| Pubmed | 3.50e-07 | 5 | 115 | 3 | 19801662 | ||
| Pubmed | 3.50e-07 | 5 | 115 | 3 | 26565025 | ||
| Pubmed | 3.50e-07 | 5 | 115 | 3 | 15247230 | ||
| Pubmed | 3.50e-07 | 5 | 115 | 3 | 18456735 | ||
| Pubmed | A G protein-coupled receptor and the intracellular synthase of its agonist functionally cooperate. | 3.50e-07 | 5 | 115 | 3 | 24493589 | |
| Pubmed | 3.50e-07 | 5 | 115 | 3 | 12130649 | ||
| Pubmed | 3.50e-07 | 5 | 115 | 3 | 12456688 | ||
| Pubmed | 3.50e-07 | 5 | 115 | 3 | 16039615 | ||
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | GRWD1 XRCC5 HSP90AA5P CNNM3 H2AC20 STRN4 HAGH MAPK1 MAPK3 DNAJC3 CUX1 HSP90AA1 | 4.72e-07 | 573 | 115 | 12 | 28330616 |
| Pubmed | 6.99e-07 | 6 | 115 | 3 | 28825193 | ||
| Pubmed | 6.99e-07 | 6 | 115 | 3 | 19589780 | ||
| Pubmed | Noncanonical TGFβ signaling contributes to aortic aneurysm progression in Marfan syndrome mice. | 6.99e-07 | 6 | 115 | 3 | 21493862 | |
| Pubmed | 6.99e-07 | 6 | 115 | 3 | 16820791 | ||
| Pubmed | 6.99e-07 | 6 | 115 | 3 | 16723512 | ||
| Pubmed | 6.99e-07 | 6 | 115 | 3 | 21713404 | ||
| Pubmed | 6.99e-07 | 6 | 115 | 3 | 12880367 | ||
| Pubmed | CUL2 FUT10 MARK3 SIK3 STT3A STT3B NSD3 AP2A1 DNAH17 MAPK1 MAPK3 MAPK4 FYN | 9.47e-07 | 730 | 115 | 13 | 34857952 | |
| Pubmed | 1.22e-06 | 7 | 115 | 3 | 37795611 | ||
| Pubmed | 1.22e-06 | 7 | 115 | 3 | 21292498 | ||
| Pubmed | 1.22e-06 | 7 | 115 | 3 | 21295571 | ||
| Pubmed | CUL2 POGLUT3 PIGK APOB PSME1 XRCC5 STT3A STT3B NSD3 TGFB1 IVNS1ABP AP2A1 HAGH FYN DNAJC3 NIPBL HSP90AA1 | 1.30e-06 | 1297 | 115 | 17 | 33545068 | |
| Pubmed | Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. | CUL2 MAGED1 HAGHL RBL2 CNNM3 PIP4K2A STRN4 MAPK1 TP53RK HSP90AA1 | 1.84e-06 | 432 | 115 | 10 | 23455922 |
| Pubmed | OR2A14 OR2J2 OR2F1 OR10Z1 OR2K2 OR10AG1 OR4C15 OR2AT4 OR2Z1 OR4C5 OR2W6P | 1.93e-06 | 541 | 115 | 11 | 14983052 | |
| Pubmed | 1.95e-06 | 8 | 115 | 3 | 19161227 | ||
| Pubmed | 2.92e-06 | 9 | 115 | 3 | 14530346 | ||
| Pubmed | STK11 is required for the normal program of ciliated cell differentiation in airways. | 3.33e-06 | 31 | 115 | 4 | 31636950 | |
| Pubmed | MAP2K4 MAGED1 CENPE SIK3 XRCC5 ARPC2 AP2A1 STRN4 DOCK7 MAPK1 MAPK3 NIPBL CUX1 HSP90AA1 | 3.78e-06 | 963 | 115 | 14 | 28671696 | |
| Pubmed | IRX3/5 regulate mitotic chromatid segregation and limb bud shape. | 4.16e-06 | 10 | 115 | 3 | 32907847 | |
| Pubmed | TGFβ pathway is required for viable gestation of Fanconi anemia embryos. | 4.16e-06 | 10 | 115 | 3 | 36441774 | |
| Pubmed | 5.70e-06 | 11 | 115 | 3 | 27504805 | ||
| Pubmed | 5.70e-06 | 11 | 115 | 3 | 27680501 | ||
| Pubmed | 5.70e-06 | 11 | 115 | 3 | 18499741 | ||
| Pubmed | MAP4K4 is involved in the neuronal development of retinal photoreceptors. | 7.58e-06 | 12 | 115 | 3 | 37290629 | |
| Pubmed | A mutation in Ccdc39 causes neonatal hydrocephalus with abnormal motile cilia development in mice. | 7.58e-06 | 12 | 115 | 3 | 29317443 | |
| Pubmed | 9.83e-06 | 13 | 115 | 3 | 25698753 | ||
| Pubmed | A mouse model for Costello syndrome reveals an Ang II-mediated hypertensive condition. | 9.83e-06 | 13 | 115 | 3 | 18483625 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | SMG1 MAP2K4 HAGHL MARK3 RBL2 STK17A SIK3 STT3B AP2A1 PIP4K2A MAPK1 MAPK3 FYN | 1.03e-05 | 910 | 115 | 13 | 36736316 |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 16796978 | ||
| Pubmed | Mitogen-activated protein kinase phosphorylates and regulates the HIV-1 Vif protein. | 1.08e-05 | 2 | 115 | 2 | 9792705 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 27564099 | ||
| Pubmed | A role for ERK2 in reconsolidation of fear memories in mice. | 1.08e-05 | 2 | 115 | 2 | 16504549 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 25059644 | ||
| Pubmed | MEK1-ERK1/2 signaling regulates the cardiomyocyte non-sarcomeric actin cytoskeletal network. | 1.08e-05 | 2 | 115 | 2 | 37999644 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 18070930 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 18224451 | ||
| Pubmed | Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence. | 1.08e-05 | 2 | 115 | 2 | 23993963 | |
| Pubmed | Mechanical stress promotes angiogenesis through fibroblast exosomes. | 1.08e-05 | 2 | 115 | 2 | 32962863 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 19801509 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 34316004 | ||
| Pubmed | Inhibition of the ERK pathway prevents HIVgp120-induced REM sleep increase. | 1.08e-05 | 2 | 115 | 2 | 11532249 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 15925565 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 28295277 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 15456767 | ||
| Pubmed | Regulation of insulin gene transcription by ERK1 and ERK2 in pancreatic beta cells. | 1.08e-05 | 2 | 115 | 2 | 12810726 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 12218045 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 29789577 | ||
| Pubmed | Bradykinin promotes neuron-generating division of neural progenitor cells through ERK activation. | 1.08e-05 | 2 | 115 | 2 | 27528403 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 21705143 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 16081808 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 15143154 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 12555071 | ||
| Pubmed | ERK1/2 is related to oestrogen receptor and predicts outcome in hormone-treated breast cancer. | 1.08e-05 | 2 | 115 | 2 | 25085753 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 20840867 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 19286961 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 19147767 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 20716207 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 21635820 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 17709754 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 23643895 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 28986121 | ||
| Pubmed | Calcitonin targets extracellular signal-regulated kinase signaling pathway in human cancers. | 1.08e-05 | 2 | 115 | 2 | 18055485 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 32444778 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 15322023 | ||
| Pubmed | MEK1-ERK2 signaling pathway protects myocardium from ischemic injury in vivo. | 1.08e-05 | 2 | 115 | 2 | 15096454 | |
| Pubmed | Both ERK1 and ERK2 are required for enterovirus 71 (EV71) efficient replication. | 1.08e-05 | 2 | 115 | 2 | 25803100 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 20404333 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 14634064 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 21248139 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 26566650 | ||
| Pubmed | [Effect of ERK1/2 signal pathway on the proliferation of lung fibroblast activated by SiO₂]. | 1.08e-05 | 2 | 115 | 2 | 21126445 | |
| Pubmed | Irradiation-induced G2/M checkpoint response requires ERK1/2 activation. | 1.08e-05 | 2 | 115 | 2 | 17297454 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 15542825 | ||
| Interaction | RPS6KA4 interactions | 9.77e-07 | 100 | 106 | 7 | int:RPS6KA4 | |
| GeneFamily | Olfactory receptors, family 2 | 1.10e-06 | 113 | 86 | 7 | 149 | |
| GeneFamily | STT3 oligosaccharyltransferase catalytic subunits|Oligosaccharyltransferase complex subunits | 2.24e-05 | 2 | 86 | 2 | 444 | |
| GeneFamily | Mitogen-activated protein kinases | 2.87e-05 | 13 | 86 | 3 | 651 | |
| GeneFamily | Volume regulated anion channel subunits | 2.22e-04 | 5 | 86 | 2 | 1158 | |
| GeneFamily | CUT class homeoboxes and pseudogenes | 7.88e-04 | 9 | 86 | 2 | 527 | |
| GeneFamily | Oligosaccharyltransferase complex subunits | 1.43e-03 | 12 | 86 | 2 | 445 | |
| GeneFamily | Dyneins, axonemal | 2.90e-03 | 17 | 86 | 2 | 536 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.22e-08 | 200 | 115 | 8 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | 8.43e-07 | 198 | 115 | 7 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.72e-07 | 199 | 115 | 7 | 15f7814b7074170eee7ccacaa670b1d128fc68bb | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.40e-06 | 180 | 115 | 6 | adf5db5bfa9a38b1227ab0beccd8d6f3eea67ac0 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-NK_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.40e-06 | 180 | 115 | 6 | 512c005567ad9c78cc5cc83862fc1219bcf49f60 | |
| ToppCell | multiciliated|World / shred by cell class for turbinate | 1.07e-05 | 192 | 115 | 6 | 0f89ea0deb651ca11531c51ee94e0233608d22ea | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_NK-NK_CD56bright_CD16-|bone_marrow / Manually curated celltypes from each tissue | 1.13e-05 | 194 | 115 | 6 | 5c58a2d1dd3c8ff77ce44d473239685e6b020909 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 1.17e-05 | 195 | 115 | 6 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn|World / Primary Cells by Cluster | 1.20e-05 | 196 | 115 | 6 | 9401bd84798f0ea3e986e94135a9e1dc5643330f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.20e-05 | 196 | 115 | 6 | 17f17edadafdad9f24e88d708d7e1c765503131c | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 1.31e-05 | 199 | 115 | 6 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-05 | 200 | 115 | 6 | b992eeddee38e6fe3564e9b1850f6b20b89bf47d | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.35e-05 | 200 | 115 | 6 | cf191104484bfb2b9f87de416b9453135f8833c1 | |
| ToppCell | LPS_IL1RA-Epithelial_airway|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.35e-05 | 200 | 115 | 6 | a5ae33dd4dc1ff6e1a1eec22c4d523d5ab657607 | |
| ToppCell | (09)_Interm._secr.>cil.|World / shred by cell type by condition | 1.35e-05 | 200 | 115 | 6 | 3305e14dba12e94da42f0414fdc7a2c8caf0a183 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-H_(AT1)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.47e-05 | 157 | 115 | 5 | dd08dc19d434e94a194076c462ee273c682abf55 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-H_(AT1)|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.47e-05 | 157 | 115 | 5 | 70fd6c46db4250c7de5c4686a9500689402737f6 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.16e-05 | 161 | 115 | 5 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-TRGV2_gdT|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.12e-05 | 166 | 115 | 5 | 62523e635784512b3261b672beaa7747cb9d114a | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 7.33e-05 | 167 | 115 | 5 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-TRGV5/7_gdT|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.53e-05 | 168 | 115 | 5 | 235c368669c017e13a7312fce3d8b91d7d106c7a | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-NK_T_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.53e-05 | 168 | 115 | 5 | b4b73f3fc9f4c3d87ca0a63ff8b2842141ccd0e6 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-NK_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.19e-05 | 171 | 115 | 5 | f16cb64b8844c2668922c786888efaa9f873afcc | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-NK_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.63e-05 | 177 | 115 | 5 | fcdd71e2a727ae24b726a39216ea02c06df1f593 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-04 | 182 | 115 | 5 | c6172aca2475bf0948a78e39f0dae6388504a915 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-NK_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-04 | 182 | 115 | 5 | feda21c92d30848de70c8b404eaabbca3f5e894d | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.10e-04 | 182 | 115 | 5 | 9d727ab84da8de33f1021b492c90d8b4c2a8ea23 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.10e-04 | 182 | 115 | 5 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | Epithelial-lung_goblet_cell|World / Lineage, Cell type, age group and donor | 1.13e-04 | 183 | 115 | 5 | 940cbe298e9c53b5622af09264586ed823d3141f | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-1|ILC / Donor, Lineage, Cell class and subclass (all cells) | 1.19e-04 | 37 | 115 | 3 | 5208860d6b87c6c6fbf6e6c262fb2efc712ec2d3 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.22e-04 | 186 | 115 | 5 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | Nasal_Brush-Immune-Neutrophils|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.22e-04 | 186 | 115 | 5 | f5aa91dbef29f7efa2b9a728c6539d7541340cd4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.22e-04 | 186 | 115 | 5 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.28e-04 | 188 | 115 | 5 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.28e-04 | 188 | 115 | 5 | 82c006f43c93f4a867953a446864f02b44536a23 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.28e-04 | 188 | 115 | 5 | da59b5c0a4b11690a39a964c1a0a83e66aa0972b | |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.31e-04 | 189 | 115 | 5 | 57ab947b81dbd9d3e896be89e28c4a62cf720837 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.31e-04 | 189 | 115 | 5 | ebc16b8eab84167d74446783d7e802acedc6b9c6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-04 | 189 | 115 | 5 | 8ff3c3232eff9de4b5c9b22ecb82bc509d773f58 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-gdT|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.34e-04 | 190 | 115 | 5 | 116314a27064d3005d950c9a9163b79ea438707b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-04 | 190 | 115 | 5 | 4836ea19308d2a96694f12ab0653b7ce7b101d2f | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated-diff|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.38e-04 | 191 | 115 | 5 | 3e84c453e8a151c42808fe2935f1d732e180008c | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 1.38e-04 | 191 | 115 | 5 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-Treg|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.41e-04 | 192 | 115 | 5 | 48d557071bad80edd3ec6e5ad8dcd97037da9553 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.41e-04 | 192 | 115 | 5 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | moderate-Lymphoid-Treg|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.41e-04 | 192 | 115 | 5 | e370ff5aaff7b7042ba9aaf93de43aa563b8b9f9 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.44e-04 | 193 | 115 | 5 | e1b76102f812c433195d1e8811fdd3293a7bc22e | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.44e-04 | 193 | 115 | 5 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | facs-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 194 | 115 | 5 | f1661f9f2439fca5c1012c693b0744c4e3b90a9b | |
| ToppCell | ILEUM-inflamed-(1)_Trm|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.48e-04 | 194 | 115 | 5 | cf22bd6afe51c42cb151c37a8b65c98649dae1a4 | |
| ToppCell | facs-Thymus-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 194 | 115 | 5 | cda1b197efb199330ea7ab25a7cee22cae22589d | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 194 | 115 | 5 | 66c056232ac216780acf4cc8ea325bd8ed1909c9 | |
| ToppCell | myeloid-CD16+_Monocyte|myeloid / Lineage and Cell class | 1.48e-04 | 194 | 115 | 5 | aeeadfeb01827dbc7de6576c76fb2e41a3c59247 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|Liver / Manually curated celltypes from each tissue | 1.52e-04 | 195 | 115 | 5 | 972b09697b7b66fb8a27dfc0c0b05a844121f055 | |
| ToppCell | T/NK_cells-CD8+_Naive_T_cell|World / Lineage and Cell class | 1.52e-04 | 195 | 115 | 5 | 43f11068beea076e9caeb1572215c3f65c9308e1 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.52e-04 | 195 | 115 | 5 | d211a836cf711fdb91b10d512f09d462be937cc5 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.52e-04 | 195 | 115 | 5 | 0e763f36786515698b593e5c93f6a56619c1242d | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo|Liver / Manually curated celltypes from each tissue | 1.52e-04 | 195 | 115 | 5 | c29c4ae95a756e3ced0f0747bbfe343590e5b8ab | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.52e-04 | 195 | 115 | 5 | 581b04220587e1d5198b1abd6965965ace7803e7 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.52e-04 | 195 | 115 | 5 | 93b1559382a12cfb158aa5fac7386e38b4f87989 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.52e-04 | 195 | 115 | 5 | 79dc031258579ea328181dda33710dd897f1064a | |
| ToppCell | NS-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.52e-04 | 195 | 115 | 5 | 34e37cff4849696ca4ba5dd8fd2cf98fed8bc912 | |
| ToppCell | (0)_NK_cells-(0)_NK_CD160pos|(0)_NK_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.52e-04 | 195 | 115 | 5 | 6cbeceb52bb207f3c074e57b5b3f7cfb24fd5877 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.52e-04 | 195 | 115 | 5 | 9651ee03738226ee10e901f8b9ec6a417eb9c301 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.55e-04 | 196 | 115 | 5 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.55e-04 | 196 | 115 | 5 | 1386003f5d885f0ea080934f7e05fe05f142a3d5 | |
| ToppCell | ILEUM-non-inflamed-(6)_ILC-(6)_ILC1|(6)_ILC / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.55e-04 | 196 | 115 | 5 | 8a3a63129adfbe58558af91336f81d397c291ed0 | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.55e-04 | 196 | 115 | 5 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-04 | 196 | 115 | 5 | 151f1a29a91f8b234e9b6ed062666357a2f69128 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.55e-04 | 196 | 115 | 5 | c366f980cc04abfe1c0c14746c11810c812a42c0 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated-diff|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.59e-04 | 197 | 115 | 5 | 32484fb5dde0a4525dd8028dde01ca5a4e51e4b6 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated-diff|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.59e-04 | 197 | 115 | 5 | 009dc732c43bfdc0d5a662b2c7d1a7a86b0d1d24 | |
| ToppCell | critical-Epithelial-Ciliated-diff|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.59e-04 | 197 | 115 | 5 | 34fa5568eb5e5f1ee5d4c7e5d237997eaca573ae | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.59e-04 | 197 | 115 | 5 | d83c61d2b5742e463122e1a98c7197a5b5b3d41b | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-IPC_like|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.63e-04 | 198 | 115 | 5 | 6d12ecaa9532c134d9c4562534dcb59a6420b4d3 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-IPC_like-IPs_and_early_cortical_neurons|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.63e-04 | 198 | 115 | 5 | 7943e4f67c3d6efb5c8b00aa0ff3cfe7be10c48d | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-04 | 198 | 115 | 5 | af07a970afaa435c6433bb5c1cbff4c67af350c7 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal-Neurons|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.63e-04 | 198 | 115 | 5 | 90ebefc9ba8dc2a81471e5693384f5ce56f06298 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-04 | 198 | 115 | 5 | fab3135f03cf23a9f04f0eed543a9dc181f39f5f | |
| ToppCell | LPS_only-Hematopoietic_Lymphocytic-Lymphocytic_NK/T-iNKT-MAIT|LPS_only / Treatment groups by lineage, cell group, cell type | 1.67e-04 | 199 | 115 | 5 | b62a756b5472972156d05051a58671a58bef1f16 | |
| ToppCell | lymphoid-T_cell-CD8+_Naive_T_cell|lymphoid / Lineage, cell class and subclass | 1.67e-04 | 199 | 115 | 5 | 22926327c93ede9f3408c99a0d56e373a33240ef | |
| ToppCell | lymphoid-T_cell-CD8+_Naive_T_cell|T_cell / Lineage, cell class and subclass | 1.67e-04 | 199 | 115 | 5 | 9ee40563e840a7fe97e7592539d42e19db438c64 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.71e-04 | 200 | 115 | 5 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 | |
| ToppCell | Biopsy_IPF-Epithelial-Differentiating_Ciliated|Biopsy_IPF / Sample group, Lineage and Cell type | 1.71e-04 | 200 | 115 | 5 | 8dfce65e417d6dcacb871d93d1539cdf807002fe | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.71e-04 | 200 | 115 | 5 | 63077e1f801f1c08bd339f5517f5781da240c04f | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.71e-04 | 200 | 115 | 5 | da12821e8a0657869ca0f75d351cce2d7605a505 | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-CD8+_Tem|URO / Disease, condition lineage and cell class | 1.71e-04 | 200 | 115 | 5 | e621b46084839700e6dd338fdafc682a07cd698d | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.71e-04 | 200 | 115 | 5 | 4992dbf0514d674017315dbd20d91dfec0c608e9 | |
| ToppCell | remission-CD8+_Tem|remission / disease stage, cell group and cell class | 1.71e-04 | 200 | 115 | 5 | f1e4b8fcb422727f665f22b48f34bee23f0fad52 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.71e-04 | 200 | 115 | 5 | f1a49bc818054fb0734d3b84725ee6487b034567 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Ciliated|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.71e-04 | 200 | 115 | 5 | d7ae09189cf0b7e2f7e7fc6b0921975b75aa7d62 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.71e-04 | 200 | 115 | 5 | 94d4f690bf5b87866c0840715396d360b1737d11 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.71e-04 | 200 | 115 | 5 | 8827653738a931e4a4545e0c7d75be12bed40740 | |
| ToppCell | severe-NK|World / disease stage, cell group and cell class | 1.71e-04 | 200 | 115 | 5 | 320cb0d79adaa1b43d90d027a876cd74f8b55ec3 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.71e-04 | 200 | 115 | 5 | cf59110547cc66b5f4a2999735336b0309ba9b0d | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.71e-04 | 200 | 115 | 5 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb | |
| ToppCell | LPS-IL1RA-Endothelial-Mes-Like|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.40e-04 | 117 | 115 | 4 | 5a23770806b4612bed4ae6fd716abdec7f7f56c6 | |
| Drug | Pyridazines | 1.19e-07 | 3 | 113 | 3 | ctd:D011724 | |
| Drug | Ro 32-0432 | 5.54e-07 | 14 | 113 | 4 | ctd:C085989 | |
| Drug | Bacterial Toxins | 1.18e-06 | 5 | 113 | 3 | ctd:D001427 | |
| Drug | NSC354462 | 2.10e-06 | 19 | 113 | 4 | CID000434668 | |
| Drug | dipropionamide | 2.36e-06 | 6 | 113 | 3 | CID000138646 | |
| Drug | dimethyl selenone | 2.36e-06 | 6 | 113 | 3 | CID000176413 | |
| Drug | octadec-9-en-1-amine | 5.66e-06 | 24 | 113 | 4 | CID000008219 | |
| Drug | thunberginol B | 6.55e-06 | 8 | 113 | 3 | CID005473310 | |
| Drug | cyanidin 3-O-glucoside | 9.24e-06 | 27 | 113 | 4 | ctd:C114438 | |
| Drug | 6-anilino-5,8-quinolinedione | 9.78e-06 | 9 | 113 | 3 | ctd:C041715 | |
| Drug | homoorientin | 9.78e-06 | 9 | 113 | 3 | ctd:C057912 | |
| Drug | CEP-1347 | 1.11e-05 | 59 | 113 | 5 | CID000133005 | |
| Drug | Peroxides | 1.39e-05 | 10 | 113 | 3 | ctd:D010545 | |
| Drug | delphinidin | 1.86e-05 | 32 | 113 | 4 | ctd:C017185 | |
| Drug | vanadyl | 2.29e-05 | 307 | 113 | 9 | CID000061671 | |
| Drug | N-acetyl glycine cysteine amide | 2.44e-05 | 2 | 113 | 2 | ctd:C510898 | |
| Drug | N-acetyl-Cys-Gly-Pro-Cys-amide | 2.44e-05 | 2 | 113 | 2 | ctd:C510899 | |
| Drug | cysteinyl-leukotriene | 2.44e-05 | 2 | 113 | 2 | ctd:C112381 | |
| Drug | NP00111 | 2.44e-05 | 2 | 113 | 2 | ctd:C530042 | |
| Drug | substance P (6-11), Tyr(6)-D-Phe(7)-D-His(9)- | 2.44e-05 | 2 | 113 | 2 | ctd:C496429 | |
| Drug | 7-methyljuglone | 2.44e-05 | 2 | 113 | 2 | ctd:C517013 | |
| Drug | sodium tetrasulfide | 2.44e-05 | 2 | 113 | 2 | ctd:C519323 | |
| Drug | 2,2',4,4',5,5'-hexabrominated diphenyl ether | 2.44e-05 | 2 | 113 | 2 | ctd:C478854 | |
| Drug | CGP 56999A | 2.44e-05 | 2 | 113 | 2 | ctd:C102659 | |
| Drug | AG 127 | 2.44e-05 | 2 | 113 | 2 | ctd:C069028 | |
| Drug | NF023 | 2.44e-05 | 2 | 113 | 2 | ctd:C105374 | |
| Drug | tyrphostin 51 | 2.44e-05 | 2 | 113 | 2 | ctd:C118515 | |
| Drug | L 759656 | 2.44e-05 | 2 | 113 | 2 | ctd:C118949 | |
| Drug | 4-O-methyl-12-O-tetradecanoylphorbol 13-acetate | 2.53e-05 | 12 | 113 | 3 | ctd:C020922 | |
| Drug | Antigens | 2.53e-05 | 12 | 113 | 3 | ctd:D000941 | |
| Drug | 14,15-epoxy-5,8,11-eicosatrienoic acid | 2.53e-05 | 12 | 113 | 3 | ctd:C046782 | |
| Drug | Tetracaine | 2.53e-05 | 12 | 113 | 3 | ctd:D013748 | |
| Drug | oleoyl-lysophosphatidic acid | MAP2K4 MCHR1 RBL2 NT5C3A SLC7A7 TGFB1 MAPK1 MAPK3 MAPK4 CUX1 | 2.57e-05 | 391 | 113 | 10 | CID000003987 |
| Drug | N-(4-aminobutyl)-1-naphthalenesulfonamide | 3.28e-05 | 13 | 113 | 3 | CID000005679 | |
| Drug | LR-90 | 4.16e-05 | 14 | 113 | 3 | ctd:C485003 | |
| Drug | inchinko-to | 4.16e-05 | 14 | 113 | 3 | ctd:C078038 | |
| Drug | SB202474 | 4.16e-05 | 14 | 113 | 3 | CID000005162 | |
| Drug | Quinoxalines | 4.16e-05 | 14 | 113 | 3 | ctd:D011810 | |
| Drug | Proscillaridin A [466-06-8]; Down 200; 7.6uM; HL60; HT_HG-U133A | 4.62e-05 | 190 | 113 | 7 | 2920_DN | |
| Drug | 2-(2-(4-(4-nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonate | 5.19e-05 | 15 | 113 | 3 | ctd:C101670 | |
| Drug | PQ 401 | 7.30e-05 | 3 | 113 | 2 | ctd:C569479 | |
| Drug | cassine | 7.30e-05 | 3 | 113 | 2 | ctd:C426663 | |
| Drug | manganese(III) acetate dihydrate | 7.30e-05 | 3 | 113 | 2 | ctd:C521134 | |
| Drug | Nipaam-ntbam copolymer | 7.30e-05 | 3 | 113 | 2 | CID003080965 | |
| Drug | delta(4)-tibolone | 7.30e-05 | 3 | 113 | 2 | ctd:C485706 | |
| Drug | tPA stop | 7.30e-05 | 3 | 113 | 2 | ctd:C115645 | |
| Drug | LBT 613 | 7.30e-05 | 3 | 113 | 2 | ctd:C514877 | |
| Drug | AAL 881 | 7.30e-05 | 3 | 113 | 2 | ctd:C514876 | |
| Drug | NGB 2904 | 7.30e-05 | 3 | 113 | 2 | ctd:C116818 | |
| Drug | 19-epi-okadaic acid | 7.30e-05 | 3 | 113 | 2 | ctd:C522300 | |
| Drug | alpha-methyl-4-carboxyphenylglycine | 7.30e-05 | 3 | 113 | 2 | ctd:C079694 | |
| Drug | 5-chloro-2-methyl-3-(1,2,3,6-tetrahydro-4-pyridinyl)-1H-indole | 7.30e-05 | 3 | 113 | 2 | ctd:C534240 | |
| Drug | YM-254890 | 7.30e-05 | 3 | 113 | 2 | ctd:C475455 | |
| Drug | poly(N-isopropylacrylamide-N-tert-butylacrylamide)copolymer | 7.30e-05 | 3 | 113 | 2 | ctd:C079805 | |
| Drug | capsanthin | 7.30e-05 | 3 | 113 | 2 | ctd:C006889 | |
| Drug | hispidulin | 7.30e-05 | 3 | 113 | 2 | ctd:C055957 | |
| Drug | bromoxynil octanoate | 7.30e-05 | 3 | 113 | 2 | ctd:C028382 | |
| Drug | 3,5-diiodothyropropionic acid | 7.30e-05 | 3 | 113 | 2 | ctd:C082182 | |
| Drug | SB 258585 | 7.30e-05 | 3 | 113 | 2 | ctd:C418570 | |
| Drug | connective tissue-activating peptide | 7.30e-05 | 3 | 113 | 2 | ctd:C009862 | |
| Drug | spectaline | 7.30e-05 | 3 | 113 | 2 | ctd:C480880 | |
| Drug | p38alpha inhibitor CMPD1 | 7.30e-05 | 3 | 113 | 2 | ctd:C492719 | |
| Drug | OR486 | 7.30e-05 | 3 | 113 | 2 | ctd:C057726 | |
| Drug | 20(R)-ginsenoside Rg2 | 7.30e-05 | 3 | 113 | 2 | CID000157711 | |
| Drug | GW2974 | 7.30e-05 | 3 | 113 | 2 | ctd:C506645 | |
| Drug | kaempferol-7-methyl ether | 7.30e-05 | 3 | 113 | 2 | ctd:C541117 | |
| Drug | wogonoside | 7.30e-05 | 3 | 113 | 2 | ctd:C473995 | |
| Drug | Ginkgolides | 7.30e-05 | 3 | 113 | 2 | ctd:D046934 | |
| Drug | ML 204 | 7.30e-05 | 3 | 113 | 2 | ctd:C567966 | |
| Drug | hwanggunchungyitang | 7.30e-05 | 3 | 113 | 2 | ctd:C539018 | |
| Drug | BPC96 peptide | 7.30e-05 | 3 | 113 | 2 | ctd:C555919 | |
| Drug | N,N''-1,4-butanediylbis(N'-(3-isothiocyanatophenyl))thiourea | 7.30e-05 | 3 | 113 | 2 | ctd:C541384 | |
| Drug | AC1L18JE | 7.69e-05 | 17 | 113 | 3 | CID000050153 | |
| Drug | N,N'-bis(salicylideneamino)ethane-manganese(II) | 7.69e-05 | 17 | 113 | 3 | ctd:C090577 | |
| Drug | O(2)-(2,4-dinitrophenyl) 1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate | 7.69e-05 | 17 | 113 | 3 | ctd:C474958 | |
| Drug | calcium silicate | 7.69e-05 | 17 | 113 | 3 | ctd:C031293 | |
| Drug | bicyclol | 7.69e-05 | 17 | 113 | 3 | ctd:C477843 | |
| Drug | RG-13577 | 7.69e-05 | 17 | 113 | 3 | CID003081306 | |
| Drug | Endosulfan | MAP2K4 MCF2 XRCC5 MYSM1 SLCO1B7 MAPK1 ALDH3A1 MAPK3 CNGA1 ALOX12B | 7.89e-05 | 447 | 113 | 10 | ctd:D004726 |
| Drug | alpha-ketoisovalerate | 8.21e-05 | 89 | 113 | 5 | CID000000049 | |
| Drug | Ly-364947 | 9.20e-05 | 18 | 113 | 3 | ctd:C520284 | |
| Drug | diphenyliodonium | 9.20e-05 | 18 | 113 | 3 | ctd:C031291 | |
| Drug | 1,3-bis(4-hydroxyphenyl)-4-methyl-5-(4-(2-piperidinylethoxy)phenol)-1H-pyrazole | 9.20e-05 | 18 | 113 | 3 | ctd:C524478 | |
| Drug | DENSPM | 9.46e-05 | 48 | 113 | 4 | CID000004282 | |
| Drug | pyrimidin-2-one beta-ribofuranoside | 9.46e-05 | 48 | 113 | 4 | ctd:C009131 | |
| Drug | NIH-3 | 1.09e-04 | 19 | 113 | 3 | CID009822007 | |
| Drug | FTI 277 | 1.09e-04 | 19 | 113 | 3 | ctd:C096856 | |
| Drug | MolPort-016-580-972 | 1.20e-04 | 51 | 113 | 4 | CID009938589 | |
| Drug | mepyramine | 1.21e-04 | 154 | 113 | 6 | CID000004992 | |
| Drug | dihydrolipoic acid | 1.28e-04 | 20 | 113 | 3 | ctd:C015144 | |
| Drug | Thenoyltrifluoroacetone | 1.28e-04 | 20 | 113 | 3 | ctd:D013804 | |
| Drug | inhibitor of p38 kinase | 1.40e-04 | 53 | 113 | 4 | CID000027933 | |
| Drug | AC1L9K70 | 1.45e-04 | 228 | 113 | 7 | CID000446871 | |
| Drug | rhenium sulfide | 1.46e-04 | 4 | 113 | 2 | CID000159414 | |
| Drug | isosalipurposide | 1.46e-04 | 4 | 113 | 2 | ctd:C027321 | |
| Drug | diacetylbis(4-methylthiosemicarbazonato)copper(II) | 1.46e-04 | 4 | 113 | 2 | ctd:C570445 | |
| Drug | 2-(2-oxo-2-((3,7,11-trimethyl-2,6,10-dodecatrienyl)oxy)aminoethyl)phosphonic acid, (2,2-dimethyl-1-oxopropoxy)methyl ester sodium | 1.46e-04 | 4 | 113 | 2 | ctd:C436083 | |
| Drug | 2,3,4,2',3',4'-hexachlorobiphenyl | 1.46e-04 | 4 | 113 | 2 | ctd:C014218 | |
| Drug | 3-(phenylsulfonyl)-4-(2-(4-(2-(3,7,11-trimethyldodeca-2,6,10-trienylthio)benzoyl)piperazin-1-yl)ethoxy)-1,2,5-oxadiazole-2-oxide | 1.46e-04 | 4 | 113 | 2 | ctd:C559860 | |
| Drug | Purvalanol | 1.46e-04 | 4 | 113 | 2 | DB02733 | |
| Disease | cancer (implicated_via_orthology) | 8.94e-07 | 268 | 112 | 9 | DOID:162 (implicated_via_orthology) | |
| Disease | congenital disorder of glycosylation Iw (implicated_via_orthology) | 1.43e-05 | 2 | 112 | 2 | DOID:0080572 (implicated_via_orthology) | |
| Disease | Camurati-Engelmann Syndrome | 1.43e-05 | 2 | 112 | 2 | C0011989 | |
| Disease | Septicemia | 1.02e-04 | 24 | 112 | 3 | C0036690 | |
| Disease | Sepsis | 1.02e-04 | 24 | 112 | 3 | C0243026 | |
| Disease | Severe Sepsis | 1.02e-04 | 24 | 112 | 3 | C1719672 | |
| Disease | Pyemia | 1.02e-04 | 24 | 112 | 3 | C0034189 | |
| Disease | colon adenocarcinoma (is_implicated_in) | 1.30e-04 | 26 | 112 | 3 | DOID:234 (is_implicated_in) | |
| Disease | urethral obstruction (biomarker_via_orthology) | 1.42e-04 | 5 | 112 | 2 | DOID:12577 (biomarker_via_orthology) | |
| Disease | pulmonary hypertension (is_implicated_in) | 2.01e-04 | 30 | 112 | 3 | DOID:6432 (is_implicated_in) | |
| Disease | CEROID LIPOFUSCINOSIS, NEURONAL, 6 | 2.12e-04 | 6 | 112 | 2 | C1866282 | |
| Disease | Streptococcal pneumonia | 2.12e-04 | 6 | 112 | 2 | C0155862 | |
| Disease | level of Phosphatidylcholine (18:2_18:2) in blood serum | 2.12e-04 | 6 | 112 | 2 | OBA_2045106 | |
| Disease | Cholestasis, Extrahepatic | 2.44e-04 | 32 | 112 | 3 | C0005398 | |
| Disease | endometrial adenocarcinoma (is_implicated_in) | 2.96e-04 | 7 | 112 | 2 | DOID:2870 (is_implicated_in) | |
| Disease | triacylglycerol 52:4 measurement | 3.47e-04 | 36 | 112 | 3 | EFO_0010416 | |
| Disease | cholesteryl esters to total lipids in very large HDL percentage | 3.47e-04 | 36 | 112 | 3 | EFO_0022257 | |
| Disease | cholesteryl esters to total lipids in medium LDL percentage | 3.76e-04 | 37 | 112 | 3 | EFO_0022252 | |
| Disease | JT interval | 3.78e-04 | 248 | 112 | 6 | EFO_0007885 | |
| Disease | insulinoma (is_marker_for) | 3.94e-04 | 8 | 112 | 2 | DOID:3892 (is_marker_for) | |
| Disease | ureteral obstruction (implicated_via_orthology) | 5.05e-04 | 9 | 112 | 2 | DOID:5199 (implicated_via_orthology) | |
| Disease | cholesteryl esters to total lipids in small LDL percentage | 5.49e-04 | 42 | 112 | 3 | EFO_0022255 | |
| Disease | triglycerides in large LDL measurement | 5.88e-04 | 43 | 112 | 3 | EFO_0022319 | |
| Disease | cholesteryl esters to total lipids in small HDL percentage | 5.88e-04 | 43 | 112 | 3 | EFO_0022254 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 5.88e-04 | 43 | 112 | 3 | EFO_0022290 | |
| Disease | obesity (is_marker_for) | 6.05e-04 | 101 | 112 | 4 | DOID:9970 (is_marker_for) | |
| Disease | level of Triacylglycerol (51:3) in blood serum | 6.30e-04 | 10 | 112 | 2 | OBA_2045163 | |
| Disease | saturated fatty acids measurement | 6.73e-04 | 45 | 112 | 3 | EFO_0022304 | |
| Disease | lipoprotein measurement | 7.00e-04 | 105 | 112 | 4 | EFO_0004732 | |
| Disease | triacylglycerol 54:4 measurement | 7.18e-04 | 46 | 112 | 3 | EFO_0010422 | |
| Disease | intraocular pressure measurement | 7.37e-04 | 509 | 112 | 8 | EFO_0004695 | |
| Disease | level of Diacylglycerol (18:1_18:1) in blood serum | 7.68e-04 | 11 | 112 | 2 | OBA_2045170 | |
| Disease | endometrial adenocarcinoma (is_marker_for) | 7.68e-04 | 11 | 112 | 2 | DOID:2870 (is_marker_for) | |
| Disease | polyunsaturated fatty acids to total fatty acids percentage | 9.16e-04 | 50 | 112 | 3 | EFO_0022303 | |
| Disease | Trigeminal Neuralgia | 9.19e-04 | 12 | 112 | 2 | C0040997 | |
| Disease | Secondary Trigeminal Neuralgia | 9.19e-04 | 12 | 112 | 2 | C0393787 | |
| Disease | Trigeminal Neuralgia, Idiopathic | 9.19e-04 | 12 | 112 | 2 | C0393786 | |
| Disease | phospholipids in very small VLDL measurement | 9.71e-04 | 51 | 112 | 3 | EFO_0022300 | |
| Disease | polyunsaturated fatty acids to monounsaturated fatty acids ratio | 9.71e-04 | 51 | 112 | 3 | EFO_0022302 | |
| Disease | cholesterol to total lipids in small HDL percentage | 9.71e-04 | 51 | 112 | 3 | EFO_0022240 | |
| Disease | phospholipids in medium VLDL measurement | 1.03e-03 | 52 | 112 | 3 | EFO_0022154 | |
| Disease | hematologic cancer (implicated_via_orthology) | 1.08e-03 | 13 | 112 | 2 | DOID:2531 (implicated_via_orthology) | |
| Disease | triglycerides in HDL measurement | 1.09e-03 | 53 | 112 | 3 | EFO_0022317 | |
| Disease | free cholesterol to total lipids in small LDL percentage | 1.09e-03 | 53 | 112 | 3 | EFO_0022286 | |
| Disease | cholesteryl esters to total lipids in very large VLDL percentage | 1.09e-03 | 53 | 112 | 3 | EFO_0022258 | |
| Disease | total lipids in medium VLDL | 1.15e-03 | 54 | 112 | 3 | EFO_0022153 | |
| Disease | triglycerides in medium HDL measurement | 1.15e-03 | 54 | 112 | 3 | EFO_0022321 | |
| Disease | cholesterol to total lipids in very large VLDL percentage | 1.15e-03 | 54 | 112 | 3 | EFO_0022244 | |
| Disease | triglycerides in medium VLDL measurement | 1.21e-03 | 55 | 112 | 3 | EFO_0022155 | |
| Disease | triglycerides in very large HDL measurement | 1.21e-03 | 55 | 112 | 3 | EFO_0022324 | |
| Disease | cholesterol to total lipids in large HDL percentage | 1.21e-03 | 55 | 112 | 3 | EFO_0022234 | |
| Disease | gastric ulcer (implicated_via_orthology) | 1.26e-03 | 14 | 112 | 2 | DOID:10808 (implicated_via_orthology) | |
| Disease | triglycerides in large VLDL measurement | 1.27e-03 | 56 | 112 | 3 | EFO_0022178 | |
| Disease | triglycerides in LDL measurement | 1.27e-03 | 56 | 112 | 3 | EFO_0022320 | |
| Disease | triglycerides in very large VLDL measurement | 1.27e-03 | 56 | 112 | 3 | EFO_0022325 | |
| Disease | triglycerides to total lipids in medium HDL percentage | 1.27e-03 | 56 | 112 | 3 | EFO_0022333 | |
| Disease | triglycerides in chylomicrons and extremely large VLDL measurement | 1.27e-03 | 56 | 112 | 3 | EFO_0022316 | |
| Disease | cholesteryl esters to total lipids in medium HDL percentage | 1.27e-03 | 56 | 112 | 3 | EFO_0022251 | |
| Disease | triglycerides in IDL measurement | 1.41e-03 | 58 | 112 | 3 | EFO_0022149 | |
| Disease | triacylglycerol 52:3 measurement | 1.45e-03 | 15 | 112 | 2 | EFO_0010415 | |
| Disease | triglycerides in VLDL measurement | 1.48e-03 | 59 | 112 | 3 | EFO_0022326 | |
| Disease | triglycerides to total lipids in small LDL percentage | 1.48e-03 | 59 | 112 | 3 | EFO_0022337 | |
| Disease | phospholipids in VLDL measurement | 1.48e-03 | 59 | 112 | 3 | EFO_0022301 | |
| Disease | concentration of chylomicrons and extremely large VLDL particles measurement | 1.48e-03 | 59 | 112 | 3 | EFO_0022260 | |
| Disease | bilirubin measurement | 1.52e-03 | 442 | 112 | 7 | EFO_0004570 | |
| Disease | phospholipids in small VLDL measurement | 1.56e-03 | 60 | 112 | 3 | EFO_0022146 | |
| Disease | triglycerides to total lipids in large HDL percentage | 1.56e-03 | 60 | 112 | 3 | EFO_0022330 | |
| Disease | cholesterol in chylomicrons and extremely large VLDL measurement | 1.56e-03 | 60 | 112 | 3 | EFO_0021898 | |
| Disease | total lipids in VLDL measurement | 1.56e-03 | 60 | 112 | 3 | EFO_0022314 | |
| Disease | cholesterol to total lipids in medium HDL percentage | 1.56e-03 | 60 | 112 | 3 | EFO_0022237 | |
| Disease | polyunsaturated fatty acid measurement | 1.59e-03 | 131 | 112 | 4 | EFO_0010733 | |
| Disease | triglycerides in small VLDL measurement | 1.63e-03 | 61 | 112 | 3 | EFO_0022145 | |
| Disease | free cholesterol in very large VLDL measurement | 1.63e-03 | 61 | 112 | 3 | EFO_0022274 | |
| Disease | free cholesterol in VLDL measurement | 1.63e-03 | 61 | 112 | 3 | EFO_0022276 | |
| Disease | triglycerides in small HDL measurement | 1.71e-03 | 62 | 112 | 3 | EFO_0022158 | |
| Disease | phospholipids in large VLDL measurement | 1.71e-03 | 62 | 112 | 3 | EFO_0022169 | |
| Disease | triglycerides in medium LDL measurement | 1.71e-03 | 62 | 112 | 3 | EFO_0022322 | |
| Disease | triglycerides to total lipids in very large HDL percentage | 1.71e-03 | 62 | 112 | 3 | EFO_0022339 | |
| Disease | total lipids in chylomicrons and extremely large VLDL measurement | 1.71e-03 | 62 | 112 | 3 | EFO_0022306 | |
| Disease | total lipids in very large VLDL measurement | 1.71e-03 | 62 | 112 | 3 | EFO_0022313 | |
| Disease | free cholesterol in chylomicrons and extremely large VLDL measurement | 1.71e-03 | 62 | 112 | 3 | EFO_0022263 | |
| Disease | phospholipids in very large VLDL measurement | 1.71e-03 | 62 | 112 | 3 | EFO_0022299 | |
| Disease | ovarian neoplasm | 1.73e-03 | 134 | 112 | 4 | C0919267 | |
| Disease | coronary artery disease, plasminogen activator inhibitor 1 measurement | 1.79e-03 | 63 | 112 | 3 | EFO_0001645, EFO_0004792 | |
| Disease | triglycerides to total lipids in IDL percentage | 1.79e-03 | 63 | 112 | 3 | EFO_0022329 | |
| Disease | free cholesterol to total lipids in medium LDL percentage | 1.79e-03 | 63 | 112 | 3 | EFO_0022283 | |
| Disease | phospholipids in chylomicrons and extremely large VLDL measurement | 1.79e-03 | 63 | 112 | 3 | EFO_0022292 | |
| Disease | Astrocytosis | 1.87e-03 | 17 | 112 | 2 | C3887640 | |
| Disease | Gliosis | 1.87e-03 | 17 | 112 | 2 | C0017639 | |
| Disease | Malignant neoplasm of ovary | 1.87e-03 | 137 | 112 | 4 | C1140680 | |
| Disease | gestational age | 1.93e-03 | 138 | 112 | 4 | EFO_0005112 | |
| Disease | triglycerides in small LDL measurement | 1.96e-03 | 65 | 112 | 3 | EFO_0022323 | |
| Disease | cholesterol in large VLDL measurement | 1.96e-03 | 65 | 112 | 3 | EFO_0021902 | |
| Disease | cholesterol in very large VLDL measurement | 1.96e-03 | 65 | 112 | 3 | EFO_0022230 | |
| Disease | Schizophrenia | MCHR1 BLOC1S1 TGFB1 PTPRZ1 PIP4K2A HAGH MAPK1 ALDH3A1 MAPK3 FYN | 1.99e-03 | 883 | 112 | 10 | C0036341 |
| Disease | Hypertrophy | 2.10e-03 | 18 | 112 | 2 | C0020564 | |
| Disease | total lipids in small VLDL | 2.14e-03 | 67 | 112 | 3 | EFO_0022148 | |
| Disease | total lipids in large VLDL | 2.14e-03 | 67 | 112 | 3 | EFO_0022175 | |
| Disease | cholesterol to total lipids in very small VLDL percentage | 2.14e-03 | 67 | 112 | 3 | EFO_0022245 | |
| Disease | triglycerides in very small VLDL measurement | 2.23e-03 | 68 | 112 | 3 | EFO_0022144 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ELLEKYMDSYDIVLV | 306 | Q9H0P0 | |
| ILVMVLVDYSITDTY | 936 | P48751 | |
| LDMRTIATALEYVYK | 131 | P78537 | |
| EVYMYQEVDTIELTR | 936 | P39880 | |
| YEEVVYVLEEIEYMI | 61 | P30838 | |
| RAVIHYRDDETMYVE | 141 | O15144 | |
| YMAAVLEYLTAEILE | 51 | Q16777 | |
| VSEMLRYLETADYAI | 406 | O95782 | |
| YMYREVDTLELTRQV | 891 | O14529 | |
| RAEAYLIEEMYDEAI | 346 | Q13217 | |
| SIIRVEYSLMVYVDI | 281 | Q96B67 | |
| FILMYEERAVEVACY | 366 | P45985 | |
| EKARMIYEDYISILS | 131 | Q9UGC6 | |
| DNYMYLVIEELTREA | 11 | Q6PII5 | |
| SLDYEESRFYLMEVV | 306 | Q9Y5G8 | |
| RTHVEEGDIVYRLYM | 251 | Q8IWT6 | |
| KTTYYIMRDLEALVT | 441 | Q15124 | |
| EMLYYKVLESVIEQE | 496 | Q08999 | |
| VYIVQDLMETDLYKL | 101 | P28482 | |
| CLILVVMSYDRYADI | 111 | Q96R47 | |
| TECLLLTVMAYDRYV | 101 | Q8NH19 | |
| VIVLTAMAYDRYVAI | 111 | Q8NGM1 | |
| DRYAYRDSMTDVIVQ | 361 | Q9HBG6 | |
| EMLRDIIREYTDVYP | 496 | Q9Y5V3 | |
| ELVMDEEAYVLYHRA | 46 | Q9BQ67 | |
| DSLEELMEEVQTLYY | 211 | Q9Y6Y0 | |
| AYIVQEYMETDLARL | 101 | P31152 | |
| TAVYYVLADLVMLTL | 101 | Q6ZP29 | |
| YMYLVIDDETKEAAI | 61 | Q16775 | |
| SLELLVAEDYMIVYL | 221 | Q86WG3 | |
| REIYYITEDMSIRIQ | 86 | Q2LD37 | |
| IVSRIMAGLLENYYE | 196 | Q9NYF5 | |
| LEVIYMIELIDKYCV | 201 | Q58FG0 | |
| TEDRDRMTSVIAYVY | 426 | Q9HCM2 | |
| VECVLLAVMAYDRYA | 116 | Q8NHA6 | |
| EGVLLVLMSYDRYVA | 111 | Q8NG97 | |
| AEQYYDMLIERILDT | 1846 | Q6KC79 | |
| RDVYIVQDLMETDLY | 116 | P27361 | |
| EEGDILYTMYIRQTV | 246 | Q6NSJ5 | |
| EFVLLAVMAYDRYVA | 111 | Q13607 | |
| RVVYDTMIEKFAVLY | 336 | P23471 | |
| AECVLLVVMSYDRYV | 111 | O76002 | |
| IETAREISYLESEMY | 71 | Q8IYI6 | |
| YMAAVLEYLTAEILE | 51 | Q6FI13 | |
| MDRYTFYVLEFLEEI | 246 | Q92643 | |
| YSLERDQLIAMTYTV | 266 | Q8NGY1 | |
| DEDYTYLILRVIGNM | 481 | P04114 | |
| ALVAEYLSMLEDRKY | 1716 | Q96N67 | |
| YLAEYIRTEMLEGDV | 4106 | Q9UFH2 | |
| DRDSYVRELMTYIEV | 226 | Q6P4F1 | |
| VRELMTYIEVDSYGE | 231 | Q6P4F1 | |
| AVVSEEPIYIVTEYM | 331 | P06241 | |
| LLDILETENSYYLVM | 126 | P57058 | |
| VLESEEQVLVMYHRY | 76 | Q13617 | |
| VKDEYELYMATLLES | 291 | Q5T5N4 | |
| ELAYVIQRYREVHDM | 151 | Q9Y3A0 | |
| LDDLYREMVRCYVEI | 76 | Q8NDY3 | |
| QIILDLAVYRYMDTS | 316 | Q86X45 | |
| LAVYRYMDTSLIDVD | 321 | Q86X45 | |
| EIRMTIAAYQTLYES | 156 | O14645 | |
| VMVRALSELTYDSLY | 466 | O75342 | |
| VIETEKTLYLIMEYA | 121 | P27448 | |
| VRELYTVLLGYRAEM | 511 | P10911 | |
| YILTAMAIDRYLATV | 201 | Q99705 | |
| YYLMDDTVEIREVHE | 266 | Q5JVL4 | |
| REDYLVEAMEILELY | 61 | P53990 | |
| KIREIVLSYSYIAMD | 26 | Q9UFF9 | |
| LEVIYMIEPIDEYCV | 516 | P07900 | |
| TYDTVLQLEYLDMVV | 346 | P24462 | |
| YLLRKMVEEVFDVLY | 126 | Q9UHL9 | |
| RMILYEDDSVQVQYV | 6 | Q96MH7 | |
| RYREMSYKVTELLEE | 126 | Q9UNA4 | |
| RRYEVIMTAYNIIGE | 1671 | Q7Z5N4 | |
| VMEIRNAYAVLYDII | 216 | Q06323 | |
| LLRVSYMEIYNETIT | 126 | Q02224 | |
| LIYKDVEDMITYREQ | 581 | O14772 | |
| MYRLNVDGVEIYVIV | 181 | P48426 | |
| EAFILVVMAYDRYVA | 116 | A6NND4 | |
| AEDRMIRFVEYYLTS | 421 | Q9BXB4 | |
| ECVLLAVMAYDRYVA | 111 | Q8NGT1 | |
| VEIILLVVMAYDCYV | 131 | Q8NGB2 | |
| LLCYIMETDYVEALT | 526 | A6NES4 | |
| EVSYMEIYNEKVRDL | 146 | Q9H1H9 | |
| SIDEMDLEVRDYYLS | 116 | A5PLK6 | |
| VATEREYVRALEYTM | 741 | Q58EX7 | |
| YIVLDKAEYLRDMEA | 121 | O43913 | |
| EAYVTDVLYRVMRCV | 426 | Q96Q15 | |
| AYEIMRELDVSYVLV | 566 | P46977 | |
| VMETERMIYLVTEYA | 131 | Q9Y2K2 | |
| MYVDIGYVDLSTIRI | 186 | G3V0H7 | |
| LMEEMILYYSVSEER | 941 | Q8NHU6 | |
| EVYETASEMILVLEY | 126 | Q9UEE5 | |
| EGYLYVMSRVDDVIN | 546 | Q9H6R3 | |
| YVSDIVYLIDMFVRT | 201 | P29973 | |
| VYEEERSNIVDMLYL | 351 | Q8NE01 | |
| MYETVDEGLKIEVLY | 106 | Q7Z4H8 | |
| ALLDTTEKYLYRDVM | 56 | Q8N587 | |
| LRSDIFEEVLNYMYT | 81 | O43829 | |
| KIEGEVRERMLVSYY | 156 | Q12768 | |
| VAMEILAYLAYETVA | 216 | O75486 | |
| RYSEDDVATYMVQLL | 3056 | Q15772 | |
| YKIMRTLDVDYVLVI | 646 | Q8TCJ2 | |
| ADYYAKEVTRVLMVE | 101 | P01137 | |
| LTNVAYYTVLDMRDI | 276 | Q9UM01 | |
| EEMLQVLIYIVGERY | 741 | Q8IWV7 | |
| MTREERIEQYTFIYI | 381 | Q9BZ95 | |
| LYMEEIEGSVTVRDY | 111 | Q96S44 | |
| LEMLLEYLQDYTDRV | 186 | Q12874 | |
| YLEEVGYTDTILDMR | 181 | Q9NRL3 | |
| VERYEMPRHEVYVLL | 681 | Q6UXY8 | |
| MQYLELTKREVEYIA | 121 | A3KMH1 | |
| YEIFETSDGRIYIIM | 76 | Q96PF2 | |
| DLDMVAIVRYAYDKR | 386 | P13010 | |
| RSMEQEETYLELYLD | 31 | Q6SJ96 | |
| TLRMLIDYVYTAEIQ | 106 | O95198 | |
| YFVDYGSEMILERLL | 1396 | Q13402 | |
| EAEAEVELYYMILER | 191 | Q14CX7 | |
| NRAVIEKMLLEEEYY | 61 | Q5VVJ2 |